Hesse I F, Johns E J
Br J Pharmacol. 1985 Mar;84(3):715-24. doi: 10.1111/j.1476-5381.1985.tb16154.x.
A study was undertaken in the anaesthetized rabbit to classify the alpha-adrenoceptor subtypes responsible for increasing renal tubular sodium reabsorption and renin secretion. Intrarenal administration of noradrenaline, at doses which did not change renal blood flow or glomerular filtration rate, significantly decreased urine flow, absolute and fractional sodium excretion by between 26% and 29%. These renal responses to noradrenaline were abolished by the selective alpha 1-adrenoceptor antagonist, prazosin, but not by the selective alpha 2-adrenoceptor antagonist, idazoxan. Noradrenaline, given intrarenally, increased renin secretion between two and three fold and this response was not modified by either prazosin or idazoxan. Intrarenal administration of the selective alpha-adrenoceptor agonists, phenylephrine and methoxamine, at dose rates which did not change renal haemodynamics, significantly reduced urine flow, absolute and fractional sodium excretion by 15% to 33%, but at doses which reduced blood flow and filtration rate, by between 11% and 26%, urine flow, absolute and fractional sodium excretion decreased between 42% and 49%. Infusion of guanabenz (selective alpha 2-adrenoceptor agonist), at doses with no renal haemodynamic action, increased urine flow, absolute and fractional sodium excretion by 11% to 15%, while at doses which decreased blood flow by 7%, these other variables did not change. Administration of UK 14304 (selective alpha 2-adrenoceptor agonist) reduced blood flow and filtration rate by 3% and 9% respectively but had no other measurable action. At higher doses, which decreased blood flow by 14% and filtration rate by 24%, urine flow, absolute and fractional sodium excretion fell by between 27% and 50%. Renin secretion was significantly increased by the high doses of phenylephrine and UK 14304 but not by the low doses of these drugs. These studies show that adrenergic stimulation of renal tubular sodium reabsorption involves the activation of alpha 1- but not alpha 2-adrenoceptors. Further, adrenergic activation of the juxtaglomerular cells to release renin does not appear to involve either alpha 1- or alpha 2-adrenoceptors.
在麻醉兔身上进行了一项研究,以对负责增加肾小管钠重吸收和肾素分泌的α-肾上腺素能受体亚型进行分类。肾内给予去甲肾上腺素,剂量不改变肾血流量或肾小球滤过率,显著降低尿流量、绝对和分数钠排泄量26%至29%。去甲肾上腺素的这些肾脏反应被选择性α1-肾上腺素能受体拮抗剂哌唑嗪消除,但未被选择性α2-肾上腺素能受体拮抗剂咪唑克生消除。肾内给予去甲肾上腺素使肾素分泌增加两到三倍,且该反应未被哌唑嗪或咪唑克生改变。肾内给予选择性α-肾上腺素能激动剂去氧肾上腺素和甲氧明,剂量率不改变肾血流动力学,显著降低尿流量、绝对和分数钠排泄量15%至33%,但在降低血流量和滤过率11%至26%的剂量下,尿流量、绝对和分数钠排泄量减少42%至49%。输注胍法辛(选择性α2-肾上腺素能激动剂),剂量无肾血流动力学作用,使尿流量、绝对和分数钠排泄量增加11%至15%,而在使血流量降低7%的剂量下,这些其他变量未改变。给予UK 14304(选择性α2-肾上腺素能激动剂)分别使血流量和滤过率降低3%和9%,但无其他可测量作用。在更高剂量下,使血流量降低14%,滤过率降低24%,尿流量、绝对和分数钠排泄量下降27%至50%。高剂量的去氧肾上腺素和UK 14304使肾素分泌显著增加,但低剂量的这些药物则无此作用。这些研究表明,肾上腺素能刺激肾小管钠重吸收涉及α1-而非α2-肾上腺素能受体的激活。此外,肾上腺素能激活球旁细胞释放肾素似乎不涉及α1-或α2-肾上腺素能受体。